CXCL13 and myeloid sarcoma: Among these factors, increased CSF levels of CXCL13, one of the most important chemokine regulating B cell migration and differentiation in MS patients and EAE models [7–9], corroborate the hypothesis that the abnormal B cell immune response persists and becomes compartmentalized in the CNS.